Welcome to today's Medical News Today News Alert containing today's medical news headlines for your chosen categories. You will only receive these alerts when new news is available for your chosen categories.
To unsubscribe from our news alerts, or to alter any of your subscription details (name,e-mail address etc) please see
http://www.medicalnewstoday.com/newsalerts.php?changemydetails=y .
----------------------------------------------
** BREAST CANCER News **
Cancer Research Giants Collaborate To Present The CTRC-AACR San Antonio Breast Cancer Symposium
http://www.medicalnewstoday.com/articles/131977.php
This year marks the first <a href="http://www.aacr.org/home/scientists/meetings--workshops/ctrc-aacr-san-antonio-breast-cancer-symposium.aspx" target="_blank" rel="nofollow">San Antonio Breast Cancer Symposium</a> to include the collaborative efforts of the American Association for Cancer Research, the Cancer Therapy and Research Center at the University of Texas Health Science Center at San Antonio and the Baylor College of Medicine.
----------------------------------------------
** CANCER / ONCOLOGY News **
Cancer Research Giants Collaborate To Present The CTRC-AACR San Antonio Breast Cancer Symposium
http://www.medicalnewstoday.com/articles/131977.php
This year marks the first <a href="http://www.aacr.org/home/scientists/meetings--workshops/ctrc-aacr-san-antonio-breast-cancer-symposium.aspx" target="_blank" rel="nofollow">San Antonio Breast Cancer Symposium</a> to include the collaborative efforts of the American Association for Cancer Research, the Cancer Therapy and Research Center at the University of Texas Health Science Center at San Antonio and the Baylor College of Medicine.
Geron Announces Initiation Of Phase I Clinical Trial Of Vaccine Candidate Targeting Telomerase By Merck & Co., Inc.
http://www.medicalnewstoday.com/articles/131888.php
Geron Corporation (Nasdaq:GERN) announced today that its collaborator, Merck & Co., Inc., has initiated a Phase I clinical trial of V934/V935, a non-dendritic cell based cancer vaccine candidate targeting telomerase.
Gene Packaging Tells Story Of Cancer Development
http://www.medicalnewstoday.com/articles/131876.php
To decipher how cancer develops, Johns Hopkins Kimmel Cancer Center investigators say researchers must take a closer look at the packaging.Specifically, their findings in the December 2, 2008, issue of <I>PLoS Biology</I> point to the three dimensional chromatin packaging around genes formed by tight, rosette-like loops of Polycomb group proteins (PcG).
More Than 200 Abstracts At ASH And SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current And Pipeline Therapies
http://www.medicalnewstoday.com/articles/131869.php
More than 200 abstracts from therapies across the Novartis Oncology portfolio will be presented at two December medical congresses, providing new data and profiling potential patient benefits from ongoing collaboration with the oncology community.
VentiRx Pharmaceuticals Commences Phase I Clinical Trial Of VTX-2337, A Novel TLR8 Agonist For The Treatment Of Oncology
http://www.medicalnewstoday.com/articles/131866.php
VentiRx Pharmaceuticals, Inc., a biopharmaceutical company focused on the development of novel Toll-Like Receptor 8 (TLR8) agonists for the treatment of cancer, respiratory and autoimmune diseases, announced today that it has initiated a Phase I clinical trial of VTX-2337, a selective TLR8 agonist for the treatment of cancer.
----------------------------------------------
** CERVICAL CANCER / HPV VACCINE News **
Black Women With Cervical Cancer Appear To Have Fewer Chemotherapy-Related Side Effects Than White Women, Study Finds
http://www.medicalnewstoday.com/articles/131946.php
Black women who have advanced and recurrent cervical cancer seem to have fewer side effects from a commonly used form of chemotherapy than white women, according to a study published in the November issue of the <cite>American Journal of Obstetrics and Gynecology</cite>, <a href="http://www.
GlaxoSmithKline To Reduce Price Of HPV Vaccine Cervarix In South Africa
http://www.medicalnewstoday.com/articles/131918.php
<A href="http://www.gsk.com/" target=_new>GlaxoSmithKline</A> on Wednesday announced it will reduce the cost of its human papillomavirus vaccine Cervarix in South Africa, <A href="http://www.
BD Receives FDA Approval For The BD FocalPoint(TM) GS Imaging System To Enhance The Detection Of Cervical Cancer
http://www.medicalnewstoday.com/articles/131870.php
BD Diagnostics, a segment of BD (Becton, Dickinson and Company) (NYSE: BDX), announced today that it received U.S. Food and Drug Administration (FDA) Premarket Approval (PMA) for the BD FocalPoint(TM) GS Imaging System.
----------------------------------------------
** COLORECTAL CANCER News **
No news for this category today.
----------------------------------------------
** LUNG CANCER News **
No news for this category today.
----------------------------------------------
** LYMPHOMA / LEUKEMIA News **
Feline Leukemia May Provide Pathway For Curing Human Diseases
http://www.medicalnewstoday.com/articles/131953.php
Researchers at The Hospital for Sick Children (SickKids) are studying how feline leukemia viruses (FeLVs) - one of the leading causes of death in young cats - can be used to treat human diseases.
----------------------------------------------
** PROSTATE / PROSTATE CANCER News **
Cell Genesys And Takeda Announce Termination Of Collaboration Agreement For GVAX Immunotherapy For Prostate Cancer
http://www.medicalnewstoday.com/articles/131856.php
Cell Genesys, Inc. (Nasdaq:CEGE) and Takeda Pharmaceutical Company Limited (TSE:4502), together with its wholly owned subsidiary Millennium: The Takeda Oncology Company, today announced that they have mutually agreed to suspend the further development of GVAX immunotherapy for prostate cancer and that Takeda has ended the collaboration agreement with Cell Genesys for the development and commercialization of the product.
-------------------------------------------------------------
You are receiving this news alert e-mail because you subscribed via an online form on our web site. If you wish to unsubscribe, please visit
http://www.medicalnewstoday.com/newsalerts.php?changemydetails=y .
No comments:
Post a Comment